🇺🇸 FDA
Pipeline program

S-1

MSPAC-1

Approved small_molecule active

Quick answer

S-1 for Pancreatic Cancer is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Pancreatic Cancer
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials